Meet the team advancing LND therapeutics.
Our leadership blends clinical rigor, operational excellence, and data-driven innovation to deliver safe microbiome therapies at scale.
Saman Maleki, PhD
CEO
Associate Professor, Departments of Pathology and Laboratory Medicine, Oncology, and Medical Biophysics, Western University. Scientist, Ontario Institute for Cancer Research (OICR). Translational Immuno-Oncology Scientist, Verspeeten Family Cancer Centre, LHSC Research Institute (London, Ontario, Canada).
Michael S. Silverman, MD
CMO
Chair/Chief of Infectious Diseases, Western University (London, Ontario). Provides clinical leadership for microbiome therapeutics and trial-aligned medical strategy.
Seema Nair Parvathy, PhD
COO
Research Scientist/Adjunct Research Professor, Dept of Medicine, Schulich School of Medicine & Dentistry, Western University. Scientific Director, FMT program. Lawson Scientist.
Behnam Jabbarizadeh
CTO
Leads LND’s technology and data stack, including multi-omics pipelines, metagenomics/functional analysis, dashboards, and reproducible reporting for clinical and research partners.